Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results

Clifton David Fuller, Nguyen Dinh Dang, Samuel Wang, Prashant Desai, Mehee Choi, Charles Thomas, Martin Fuss

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Biliary tract lesions are comparatively rare neoplasms, with ambiguous indications for radiotherapy. The specific aim of this study was to report the clinical results of a single-institution biliary tract series treated with modern radiotherapeutic techniques, and detail results using both conventional and image-guided intensity-modulated radiation therapy (IG-IMRT). Methods and materials: From 2001 to 2005, 24 patients with primary adenocarcinoma of the biliary tract (gallbladder and extrahepatic bile ducts) were treated by IG-IMRT. To compare outcomes, data from a sequential series of 24 patients treated between 1995 and 2005 with conventional radiotherapy (CRT) techniques were collected as a comparator set. Demographic and treatment parameters were collected. Endpoints analyzed included treatment-related acute toxicity and survival. Results: Median estimated survival for all patients completing treatment was 13.9 months. A statistically significant higher mean dose was given to patients receiving IG-IMRT compared to CRT, 59 vs. 48 Gy. IG-IMRT and CRT cohorts had a median survival of 17.6 and 9.0 months, respectively. Surgical resection was associated with improved survival. Two patients (4%) experienced an RTOG acute toxicity score > 2. The most commonly reported GI toxicities (≥RTOG Grade 2) were nausea or diarrhea requiring oral medication, experienced by 46% of patients. Conclusion: This series presents the first clinical outcomes of biliary tract cancers treated with IG-IMRT. In comparison to a cohort of patients treated by conventional radiation techniques, IG-IMRT was feasible for biliary tract tumors, warranting further investigation in prospective clinical trials.

Original languageEnglish (US)
Pages (from-to)249-254
Number of pages6
JournalRadiotherapy and Oncology
Volume92
Issue number2
DOIs
StatePublished - Aug 2009

Fingerprint

Image-Guided Radiotherapy
Intensity-Modulated Radiotherapy
Adenocarcinoma
Biliary Tract
Radiotherapy
Survival
Biliary Tract Neoplasms
Extrahepatic Bile Ducts
Gallbladder
Nausea
Diarrhea
Neoplasms
Therapeutics
Demography
Clinical Trials
Radiation

Keywords

  • Biliary tract cancer
  • Cholangiocarcinoma
  • Gallbladder cancer
  • Image-guided radiotherapy (IGRT)
  • Intensity-modulated radiation therapy (IMRT)

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas : Initial clinical results. / Fuller, Clifton David; Dang, Nguyen Dinh; Wang, Samuel; Desai, Prashant; Choi, Mehee; Thomas, Charles; Fuss, Martin.

In: Radiotherapy and Oncology, Vol. 92, No. 2, 08.2009, p. 249-254.

Research output: Contribution to journalArticle

Fuller, Clifton David ; Dang, Nguyen Dinh ; Wang, Samuel ; Desai, Prashant ; Choi, Mehee ; Thomas, Charles ; Fuss, Martin. / Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas : Initial clinical results. In: Radiotherapy and Oncology. 2009 ; Vol. 92, No. 2. pp. 249-254.
@article{c7d7f9f940064402b28a551677bde476,
title = "Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results",
abstract = "Purpose: Biliary tract lesions are comparatively rare neoplasms, with ambiguous indications for radiotherapy. The specific aim of this study was to report the clinical results of a single-institution biliary tract series treated with modern radiotherapeutic techniques, and detail results using both conventional and image-guided intensity-modulated radiation therapy (IG-IMRT). Methods and materials: From 2001 to 2005, 24 patients with primary adenocarcinoma of the biliary tract (gallbladder and extrahepatic bile ducts) were treated by IG-IMRT. To compare outcomes, data from a sequential series of 24 patients treated between 1995 and 2005 with conventional radiotherapy (CRT) techniques were collected as a comparator set. Demographic and treatment parameters were collected. Endpoints analyzed included treatment-related acute toxicity and survival. Results: Median estimated survival for all patients completing treatment was 13.9 months. A statistically significant higher mean dose was given to patients receiving IG-IMRT compared to CRT, 59 vs. 48 Gy. IG-IMRT and CRT cohorts had a median survival of 17.6 and 9.0 months, respectively. Surgical resection was associated with improved survival. Two patients (4{\%}) experienced an RTOG acute toxicity score > 2. The most commonly reported GI toxicities (≥RTOG Grade 2) were nausea or diarrhea requiring oral medication, experienced by 46{\%} of patients. Conclusion: This series presents the first clinical outcomes of biliary tract cancers treated with IG-IMRT. In comparison to a cohort of patients treated by conventional radiation techniques, IG-IMRT was feasible for biliary tract tumors, warranting further investigation in prospective clinical trials.",
keywords = "Biliary tract cancer, Cholangiocarcinoma, Gallbladder cancer, Image-guided radiotherapy (IGRT), Intensity-modulated radiation therapy (IMRT)",
author = "Fuller, {Clifton David} and Dang, {Nguyen Dinh} and Samuel Wang and Prashant Desai and Mehee Choi and Charles Thomas and Martin Fuss",
year = "2009",
month = "8",
doi = "10.1016/j.radonc.2009.02.015",
language = "English (US)",
volume = "92",
pages = "249--254",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas

T2 - Initial clinical results

AU - Fuller, Clifton David

AU - Dang, Nguyen Dinh

AU - Wang, Samuel

AU - Desai, Prashant

AU - Choi, Mehee

AU - Thomas, Charles

AU - Fuss, Martin

PY - 2009/8

Y1 - 2009/8

N2 - Purpose: Biliary tract lesions are comparatively rare neoplasms, with ambiguous indications for radiotherapy. The specific aim of this study was to report the clinical results of a single-institution biliary tract series treated with modern radiotherapeutic techniques, and detail results using both conventional and image-guided intensity-modulated radiation therapy (IG-IMRT). Methods and materials: From 2001 to 2005, 24 patients with primary adenocarcinoma of the biliary tract (gallbladder and extrahepatic bile ducts) were treated by IG-IMRT. To compare outcomes, data from a sequential series of 24 patients treated between 1995 and 2005 with conventional radiotherapy (CRT) techniques were collected as a comparator set. Demographic and treatment parameters were collected. Endpoints analyzed included treatment-related acute toxicity and survival. Results: Median estimated survival for all patients completing treatment was 13.9 months. A statistically significant higher mean dose was given to patients receiving IG-IMRT compared to CRT, 59 vs. 48 Gy. IG-IMRT and CRT cohorts had a median survival of 17.6 and 9.0 months, respectively. Surgical resection was associated with improved survival. Two patients (4%) experienced an RTOG acute toxicity score > 2. The most commonly reported GI toxicities (≥RTOG Grade 2) were nausea or diarrhea requiring oral medication, experienced by 46% of patients. Conclusion: This series presents the first clinical outcomes of biliary tract cancers treated with IG-IMRT. In comparison to a cohort of patients treated by conventional radiation techniques, IG-IMRT was feasible for biliary tract tumors, warranting further investigation in prospective clinical trials.

AB - Purpose: Biliary tract lesions are comparatively rare neoplasms, with ambiguous indications for radiotherapy. The specific aim of this study was to report the clinical results of a single-institution biliary tract series treated with modern radiotherapeutic techniques, and detail results using both conventional and image-guided intensity-modulated radiation therapy (IG-IMRT). Methods and materials: From 2001 to 2005, 24 patients with primary adenocarcinoma of the biliary tract (gallbladder and extrahepatic bile ducts) were treated by IG-IMRT. To compare outcomes, data from a sequential series of 24 patients treated between 1995 and 2005 with conventional radiotherapy (CRT) techniques were collected as a comparator set. Demographic and treatment parameters were collected. Endpoints analyzed included treatment-related acute toxicity and survival. Results: Median estimated survival for all patients completing treatment was 13.9 months. A statistically significant higher mean dose was given to patients receiving IG-IMRT compared to CRT, 59 vs. 48 Gy. IG-IMRT and CRT cohorts had a median survival of 17.6 and 9.0 months, respectively. Surgical resection was associated with improved survival. Two patients (4%) experienced an RTOG acute toxicity score > 2. The most commonly reported GI toxicities (≥RTOG Grade 2) were nausea or diarrhea requiring oral medication, experienced by 46% of patients. Conclusion: This series presents the first clinical outcomes of biliary tract cancers treated with IG-IMRT. In comparison to a cohort of patients treated by conventional radiation techniques, IG-IMRT was feasible for biliary tract tumors, warranting further investigation in prospective clinical trials.

KW - Biliary tract cancer

KW - Cholangiocarcinoma

KW - Gallbladder cancer

KW - Image-guided radiotherapy (IGRT)

KW - Intensity-modulated radiation therapy (IMRT)

UR - http://www.scopus.com/inward/record.url?scp=67650970454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650970454&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2009.02.015

DO - 10.1016/j.radonc.2009.02.015

M3 - Article

C2 - 19324442

AN - SCOPUS:67650970454

VL - 92

SP - 249

EP - 254

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -